Urologic Device Innovation and Trends: An Analysis of Food and Drug Administration Approvals From 1990-2023
Urologic device regulatory approvals have declined since the 1990s in traditionally dominant subspecialties. While growth is emerging in underrepresented areas such as URPS and neurourology, prolonged approval timelines within these subspecialties may impede progress. Regulatory reform and industry support may help revitalize innovation in urologic technology.
Authors
- Scott G. Hubosky (ORCID: https://orcid.org/0000-0002-6381-754X)
- Antony A. Fuleihan (ORCID: https://orcid.org/0009-0002-8291-6946)
- M. E. GOLDBERG
- Whitney R. Smith
- Arjun K. Menta (ORCID: https://orcid.org/0000-0002-6371-6052)
- Sam B. Duggan
- Costas D. Lallas (ORCID: https://orcid.org/0000-0001-8937-7661)
- Patrick J. Shenot (ORCID: https://orcid.org/0000-0003-1722-1451)
- Paul H. Chung (ORCID: https://orcid.org/0000-0001-9360-1400)
- Adam R. Metwalli (ORCID: https://orcid.org/0000-0003-0365-4969)
- Leonard G. Gomella (ORCID: https://orcid.org/0000-0002-9466-489X)
- Masaya Jimbo (ORCID: https://orcid.org/0000-0002-3181-3683)
- Patrick T. Gomella (ORCID: https://orcid.org/0000-0002-2162-8150)
- Mihir Shah
- Paul Bloch
Institutions
- Johns Hopkins University (US)
- Thomas Jefferson University (US)
- Thomas Jefferson University Hospital (US)
- Johns Hopkins Medicine (US)
Publication Details
- Journal
- Urology Practice
- Published
- 2026-03-26
- DOI
- https://doi.org/10.1097/upj.0000000000001002
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00